Abstract
Tomonari Shimagaki, Atsushi Maeda, Tomoya Harima, Akihiro Sakai, Rumi Matono, Naotaka Hashimoto, Shohei Yamaguchi, Kozo Konishi, Kenkichi Hashimoto, Takashi Maeda
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
doaj
Confidence 92%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024
Meta-analysis of determinants of survival following treatment of recurrent hepatocellular carcinoma
10.1002/bjs.10597 · 2017
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): A randomised, open-label, multicentre, phase 3 trial
10.1016/s0140-6736(23)01796-8 · 2023
BCLC strategy for prognosis prediction and treatment recommendations: The 2026 update
10.1016/j.jhep.2025.10.020 · 2026
Outcome of hepatectomy after systemic therapy for hepatocellular carcinoma: A Japanese multicenter study
10.1007/s00595-024-02930-x · 2025
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
10.1097/hep.0000000000000466 · 2023
Five-year overall survival update from the HIMALAYA study of tremelimumab plus durvalumab in unresectable HCC
10.1016/j.jhep.2025.03.033 · 2025
Assessment of liver function in patients with hepatocellular carcinoma: A new evidence-based approach-the ALBI grade
10.1200/jco.2014.57.9151 · 2015
Emerging prognostic markers in patients undergoing liver resection for hepatocellular carcinoma: A narrative review
10.3390/cancers16122183 · 2024
Superiority of CRP-albumin-lymphocyte index (CALLY index) as a non-invasive prognostic biomarker after hepatectomy for hepatocellular carcinoma
10.1016/j.hpb.2021.06.414 · 2022
The impact of C-reactive protein-albumin-lymphocyte (CALLY) index on the prognosis of patients with distal cholangiocarcinoma following pancreaticoduodenectomy
10.1002/ags3.12637 · 2022
Impact of inflammation and the immune system on hepatocellular carcinoma recurrence after hepatectomy
2024
Integrating inflammation, nutrition, and immunity: the CALLY index as a prognostic tool in digestive system cancers - a systematic review and meta-analysis
10.1186/s12885-025-14074-3 · 2025
Prognostic impact of the CALLY index in patients with resectable pancreatic cancer
10.1016/j.soi.2024.100119 · 2025
The EZ-ALBI score as a prognostic tool for outcomes after resection of small hepatocellular carcinoma (</=3 cm
10.1111/hepr.14210 · 2025
The CRP-albumin-lymphocyte index provides enhanced prognostic value in liver cancer compared to the TNM staging system
10.1038/s41598-025-03985-7 · 2025
Verification of inflammation-based prognostic marker as a prognostic indicator in hepatocellular carcinoma
10.1002/ags3.12286 · 2019
Cachexia index as a prognostic predictor after resection of pancreatic ductal adenocarcinoma
10.1002/ags3.12686 · 2023
Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma
10.1111/jgh.13250 · 2016
The prognostic impact of perioperative dynamic changes in cachexia index in patients with hepatocellular carcinoma
10.1002/ags3.12804 · 2024
Clinical significance of preoperative inflammation-based score for the prognosis of patients with hepatocellular carcinoma who underwent hepatectomy
10.1007/s00595-021-02427-x · 2022
Immune microenvironment in hepatocellular carcinoma: from pathogenesis to immunotherapy
10.1038/s41423-025-01308-4 · 2025
Intrahepatic recurrence of hepatocellular carcinoma after resection: an update
10.1007/s12328-021-01394-7 · 2021
A systematic review and meta-analysis comparing the prognosis of multicentric occurrence and vs. intrahepatic metastasis in patients with recurrent hepatocellular carcinoma after hepatectomy
10.1016/j.hpb.2017.06.002 · 2017
The C-reactive protein-albumin-lymphocyte (CALLY) index is a useful predictor of postoperative complications in patients with a colonic stent for obstructive colorectal cancer: A Japanese multicenter study
10.1007/s00595-024-02924-9 · 2025
No additional external references are available.